N-isopropyl-4-methyl-2,3-dihydropyrrole | 137440-43-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯啉
• 英文名称: N-isopropyl-4-methyl-2,3-dihydropyrrole
• 英文别名: 4-Methyl-1-propan-2-yl-2,3-dihydropyrrole
• CAS: 137440-43-8
• 化学式: C₈H₁₅N
• 分子量: 125.214
• InChiKey: CWXVCNIGDNUHEF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  N-isopropyl-4,4-dibromo-3-methylbut-3-enylamine 在 甲基锂 作用下， 以 乙醚 为溶剂， 以49%的产率得到N-isopropyl-4-methyl-2,3-dihydropyrrole
  参考文献：
  名称：

  Baird, Mark S.; Baxter, Anthony G. W.; Hoorfar, Alireza, Journal of the Chemical Society. Perkin transactions I, 1991, # 4, p. 2575 - 2582

  摘要：

  DOI：

文献信息

• Novel pyridine derivatives and pyrimidine derivatives (3)
  申请人：Matsushima Tomohiro

  公开号：US20080319188A1

  公开（公告）日：2008-12-25

  A compound represented by the following formula, a salt thereof or a hydrate of the foregoing has an excellent hepatocyte growth factor receptor (HGFR) inhibitory activity, and exhibits anti-tumor activity, angiogenesis inhibitory activity and cancer metastasis inhibitory activity. [R 1 represents a 3- to 10-membered non-aromatic heterocyclic group or the like; R 2 and R 3 represent hydrogen; R 4 , R 5 , R 6 , and R 7 may be the same or different and each represents hydrogen, halogen, C 1-6 alkyl or the like; R 8 represents hydrogen or the like; R 9 represents a 3- to 10-membered non-aromatic heterocyclic group or the like; n represents an integer of 1 or 2; X represents —CH═, nitrogen or the like.]

  以下化合物，其盐或水合物，具有优异的肝细胞生长因子受体（HGFR）抑制活性，表现出抗肿瘤活性、抑制血管生成活性和癌症转移抑制活性。[其中，R1代表3-至10-成员的非芳香族杂环基团等；R2和R3代表氢；R4、R5、R6和R7可以相同或不同，每个代表氢、卤素、C1-6烷基或类似物；R8代表氢或类似物；R9代表3-至10-成员的非芳香族杂环基团等；n代表1或2的整数；X代表-CH═，氮或类似物。]
• Indole Derivative Having Pgd2 Receptor Antagonist Activity
  申请人：Kugimiya Akira

  公开号：US20090030014A1

  公开（公告）日：2009-01-29

  The present invention creates an indole derivative having DP receptor antagonistic activity and a pharmaceutical composition comprising the said compound as an active ingredient, and further a therapeutic agent for treating allergic diseases. A compound of the generic formula (I) wherein the ring A is an aromatic carbocyclic ring etc.; the ring B is a 3- to 8-membered nitrogen-containing non-aromatic heterocyclic ring etc.; R 1 , R 2 , R 3 , R 4 and R 5 are independently a hydrogen atom or a halogen atom etc.; R 6 is C2-C4 alkyloxy etc.; R 7 is independently a halogen atom etc.; R 8 is independently C1-C4 alkyl etc.; R 9 is carboxy etc.; Y is a single bond etc.; M is sulfonyl etc.; L 1 , L 2 and L 3 are a single bond or alkylene optionally containing one or two heteroatoms etc.; n is 0 etc.; q is 0 etc.; a pharmaceutically acceptable salt or hydrate thereof.
• US7855290B2
  申请人：——

  公开号：US7855290B2

  公开（公告）日：2010-12-21
• US7956082B2
  申请人：——

  公开号：US7956082B2

  公开（公告）日：2011-06-07
• Baird, Mark S.; Baxter, Anthony G. W.; Hoorfar, Alireza, Journal of the Chemical Society. Perkin transactions I, 1991, # 4, p. 2575 - 2582
  作者：Baird, Mark S.、Baxter, Anthony G. W.、Hoorfar, Alireza、Jefferies, Ian

  DOI：——

  日期：——